{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:51:20Z","timestamp":1791085880249,"version":"4.1.0"},"reference-count":17,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008494","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T14:43:38Z","timestamp":1271169818000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings"],"prefix":"10.1002","volume":"2011","author":[{"given":"Larry W","family":"Chang","sequence":"first","affiliation":[{"name":"Johns Hopkins School of Medicine; Division of Infectious Diseases, Department of Medicine; 1503 East Jefferson St. Room 116 Baltimore MD USA 21287"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Harris","sequence":"additional","affiliation":[{"name":"University of California, San Francisco; Department of Pediatrics; San Francisco California USA 94143"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza H","family":"Humphreys","sequence":"additional","affiliation":[{"name":"University of California, San Francisco; Global Health Sciences; 50 Beale Street Suite 1200 San Francisco California USA 94105"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"10.1002\/14651858.CD008494-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008494-BIB0002|cit2","first-page":"1867","article-title":"Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring","author":"Egger","year":"2009","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD008494-BIB0003|cit3","article-title":"Impact of routine laboratory monitoring over 5 years after antiretroviral therapy (ART) initiation on clinical disease progression of HIV-infected African adults: the DART trial final results","author":"Mugyenyi","year":"2009","journal-title":"5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa"},{"key":"10.1002\/14651858.CD008494-BIB0004|cit4","article-title":"Utility of routine viral load, CD4 cell count, and clinical monitoring among HIV-infected adults in Uganda: a randomized trial","author":"Coutinho","year":"2008","journal-title":"Conference on Retroviruses and Opportunistic Infections, Montreal, Canada"},{"key":"10.1002\/14651858.CD008494-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1086\/322636","article-title":"A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy","author":"Haubrich","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1002\/14651858.CD008494-BIB0006|cit6","unstructured":"Lallemant M Monitoring highly active antiretroviral therapy in HIV-infected patients in Thailand. NCT00162682"},{"key":"10.1002\/14651858.CD008494-BIB0007|cit7","unstructured":"Laurent C Antiretroviral treatment simplified follow-up management assessment (ANRS 12110 STRATALL). NCT00301561"},{"key":"10.1002\/14651858.CD008494-BIB0008|cit8","unstructured":"PENPACT1 Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children. NCT00039741"},{"key":"10.1002\/14651858.CD008494-BIB0009|cit9","unstructured":"Sagg M HIV viral load monitoring in resource-poor settings. NCT00929604"},{"issue":"9709","key":"10.1002\/14651858.CD008494-BIB0010|cit10","first-page":"123","article-title":"Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial","volume":"375","author":"DART Trial Team","journal-title":"The Lancet"},{"issue":"16","key":"10.1002\/14651858.CD008494-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1097\/QAD.0b013e328309520d","article-title":"Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching","volume":"22","author":"Elliott","year":"2008","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD008494-BIB0012|cit12","article-title":"GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2 [updated March 2009].","volume-title":"GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2 [updated March 2009]","author":"Sch\u00fcnemann","year":"2009"},{"key":"10.1002\/14651858.CD008494-BIB0013|cit13","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD008494-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/135965350701200106","article-title":"Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited","volume":"12","author":"Orrell","year":"2007","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD008494-BIB0015|cit15","unstructured":"Wells GA Shea B O'Connell D Peterson J Welch V Losos M Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm. Accessed 22 June 2009."},{"key":"10.1002\/14651858.CD008494-BIB0016|cit16","volume-title":"Antiretroviral therapy for HIV infection in adults and adolescents: towards universal access. Recommendations for a public health approach","author":"World Health Organization (WHO)","year":"2006"},{"key":"10.1002\/14651858.CD008494-BIB0017|cit17","article-title":"Rapid advice. Antiretroviral therapy for HIV infection in adults and adolescents","volume-title":"Rapid advice. Antiretroviral therapy for HIV infection in adults and adolescents","author":"World Health Organization (WHO)","year":"2009"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:05:14Z","timestamp":1789419914000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008494"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008494","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}